HCPLive Network

Rates of Community-acquired MRSA Increasing in Pediatric ICU Patients

Community-acquired MRSA infections are becoming increasingly common in pediatric ICU (PICU) patients, according to the results of a new study from Johns Hopkins Children’s Center researchers.

In 2007, lead investigator Aaron Milstone, MD, MHS, a pediatric infectious disease specialist at Children’s, and his team began screening all patients at the time of admission and then weekly until they were discharged. They found that 6% of the 1,674 children who were admitted to the PICU at Children’s between 2007 and 2008 were colonized with MRSA; 72 of the children tested positive for the infection, 60% of whom harbored the community-acquired strain. Altogether, 75% of all MRSA carriers had no previous history of the infection. For the children, an MRSA infection resulted in “longer hospital stays (eight days) than MRSA-free patients (five days), and longer PICU stays (three days) than non-colonized patients (two days).”

An additional outcome of the study revealed that eight patients who were MRSA-free at the time of their admission to the PICU became colonized with the infection during their hospital stay. Half of these children later developed clinical signs of the infection, which means, according to the researchers, “that the other four would have never been identified as MRSA carriers if the hospital was not performing weekly screenings of all patients.”

According to Milstone, “MRSA has become so widespread in the community, that it’s become nearly impossible to predict which patients harbor MRSA on their body. Point-of-admission screening in combination with other preventive steps, like isolating the patient and using contact precaution, can help curb the spread of dangerous bacterial infections to other vulnerable patients.”

The researchers also noted that MRSA was more often seen in younger children, with an average age of three years, and among African American children, though the reasons for these disparities are unclear.

Further Reading
Global efforts are needed to curb antibiotic resistance, according to a report published online Nov. 16 in The Lancet Infectious Diseases.
The FDA has approved ceftaroline fosamil to treat adults with community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
Only 2 cases of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pericarditis have been reported in the English literature. Over the last 15 years, CA-MRSA has emerged as an increasingly common pathogen that is genetically and epidemiologically different from hospital-acquired MRSA (HA-MRSA).
Methicillin-resistant Staphylococcus aureus infections are contracted many times more often by individuals with HIV, a new study has found.
Both restrictive and persuasive measures can be effective for changing antibiotic prescribing behavior in a hospital setting.
Study results show that daptomycin cleared MRSA infections within four days of treatment in 80% of patients and was particularly effective against extra-vascular infections.
Combination horizontal and vertical prevention efforts can reduce MRSA, VRE, MDR acinetobacter, and other nosocomial infections by 50%.
More Reading